Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
Jørgensen KK, Goll GL, Sexton J, Bolstad N, Olsen IC, Asak Ø, Berset IP, Blomgren IM, Dvergsnes K, Florholmen J, Frigstad SO, Henriksen M, Hagfors J, Huppertz-Hauss G, Haavardsholm EA, Klaasen RA, Moum B, Noraberg G, Prestegård U, Rydning JH, Sagatun L, Seeberg KA, Torp R, Vold C, Warren DJ, Ystrøm CM, Lundin KEA, Kvien T, Jahnsen J. Jørgensen KK, et al. Among authors: sagatun l. BioDrugs. 2020 Oct;34(5):681-694. doi: 10.1007/s40259-020-00438-7. BioDrugs. 2020. PMID: 32965617 Free PMC article. Clinical Trial.
Follow-up of patients with ECL cell-derived tumours.
Sagatun L, Fossmark R, Jianu CS, Qvigstad G, Nordrum IS, Mjønes P, Waldum HL. Sagatun L, et al. Scand J Gastroenterol. 2016 Nov;51(11):1398-405. doi: 10.3109/00365521.2016.1169588. Epub 2016 Jun 16. Scand J Gastroenterol. 2016. PMID: 27309188
The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L, Jianu CS, Fossmark R, Mårvik R, Nordrum IS, Waldum HL. Sagatun L, et al. Scand J Gastroenterol. 2014 Oct;49(10):1173-80. doi: 10.3109/00365521.2014.950979. Epub 2014 Aug 26. Scand J Gastroenterol. 2014. PMID: 25157752
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F, Fossmark R, Waldum HL, Pritchard DM. Boyce M, et al. Among authors: sagatun l. Br J Clin Pharmacol. 2017 Mar;83(3):466-475. doi: 10.1111/bcp.13146. Epub 2016 Nov 21. Br J Clin Pharmacol. 2017. PMID: 27704617 Free PMC article. Clinical Trial.
Gastrin and Gastric Cancer.
Waldum HL, Sagatun L, Mjønes P. Waldum HL, et al. Among authors: sagatun l. Front Endocrinol (Lausanne). 2017 Jan 17;8:1. doi: 10.3389/fendo.2017.00001. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28144230 Free PMC article. Review.
Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P, Nordrum IS, Sørdal Ø, Sagatun L, Fossmark R, Sandvik A, Waldum HL. Mjønes P, et al. Among authors: sagatun l. Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4. Horm Cancer. 2018. PMID: 28980157 Free PMC article.
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group. Jørgensen KK, et al. Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11. Lancet. 2017. PMID: 28502609 Clinical Trial.